Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic sclerosis in the time of COVID-19
Anna‐Maria Hoffmann‐Vold, Oliver Distler, Cosimo Bruni, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 8, pp. e566-e575
Open Access | Times Cited: 19

Showing 19 citing articles:

Systemic sclerosis
Elizabeth R. Volkmann, Kristofer Andréasson, Vanessa Smith
The Lancet (2022) Vol. 401, Iss. 10373, pp. 304-318
Open Access | Times Cited: 248
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Anne-Marie Svensson, Hanne‐Dorthe Emborg, Lars Erik Bartels, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 10, pp. 1359-1367
Closed Access | Times Cited: 6
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100212-100212
Open Access | Times Cited: 5
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Kimberly S. Lakin, Yin Wu, Jessica Gordon, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152453-152453
Closed Access | Times Cited: 1
Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases
Lazaros I. Sakkas, Ian C. Chikanza
Rheumatology International (2023) Vol. 44, Iss. 2, pp. 203-209
Open Access | Times Cited: 4
PM/Scl overlap syndrome in a 14‐year‐old girl manifesting after a SARS‐CoV‐2 infection
Lisbeth Dadak, Peter Maximilian Heil, Silvana Geleff, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 6, pp. 661-663
Open Access | Times Cited: 3
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort
Suhrud Panchawagh, Bohdana Doskaliuk, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 43, Iss. 12, pp. 2211-2220
Closed Access | Times Cited: 3
COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease
Stylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, et al.
Journal of Scleroderma and Related Disorders (2022) Vol. 8, Iss. 2, pp. 113-119
Open Access | Times Cited: 5
Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma Patient‐Centered Intervention Network (SPIN) Study
Chelsea S. Rapoport, Alyssa K. Choi, Linda Kwakkenbos, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 10, pp. 2158-2165
Open Access | Times Cited: 2
Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
Elisabeth Deibel, Patrícia Carreira, Madelon C Vonk, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 88-97
Open Access | Times Cited: 2
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2
Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study
Chelsea S. Rapoport, Alyssa K. Choi, Linda Kwakkenbos, et al.
International Journal of Behavioral Medicine (2024) Vol. 31, Iss. 3, pp. 352-362
Closed Access
Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis
Jenna M. Benoit, Jessica A. Breznik, Angela Huynh, et al.
Immunology Letters (2024), pp. 106929-106929
Open Access
Microstomia is associated with functional impairment and is a poor prognostic factor in systemic sclerosis – a single center observational study with survival analysis
Kristóf Filipánits, Gabriella Nagy, Cecília Varjú, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access
SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis
Ha Yeon Jeong, Jin‐Sil Park, Jin Seok Woo, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Lower incidence but higher mortality in COVID-19 hospitalizations among systemic sclerosis patients
Shrey Patel, Shiv Patel, Sareena Shah, et al.
JAAD International (2023) Vol. 11, pp. 8-10
Open Access
SARS-CoV-2 Spike Protein Accelerates Systemic Sclerosis by Increasing Inflammatory Cytokines, Th17 Cells, and Fibrosis
Ha Yeon Jeong, Jin‐Sil Park, Jin Seok Woo, et al.
Research Square (Research Square) (2023)
Open Access
FUNCTIONS, SLEEP, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH SCLERODERMA DURING COVID-19: CROSS - SECTIONAL STUDY
T. Civi Karaaslan, Ela Tarakçı, Ozal Keles, et al.
Türk fizyoterapi ve rehabilitasyon dergisi (2023) Vol. 34, Iss. 2, pp. 182-188
Open Access
Therapie der Kollagenose-assoziierten interstitiellen Lungenerkrankungen
Theresa Graalmann, Benjamin Seeliger
Pneumo News (2023) Vol. 15, Iss. 4, pp. 37-47
Closed Access
Page 1

Scroll to top